There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Edwards Lifesciences Corporation (EW) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$1.22, or -1.46%, to $82.37. Volume reached 159,357 shares, with price reaching a high of $82.37 and a low of $82.37. Yahoo Finance discussed the stock recently as it posted EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL.
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $82.37 and fluctuated between $84.60 as its day high and $81.87 as its day low. The current market capitalization of Edwards Lifesciences Corporation is $50.72B. A total of 3.03 million shares were traded on the day, compared to an average of 2.55M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, EW has seen 11 BUY and 16 SELL insider trades, representing the acquisition of 117,491 and the disposition of 96,170 shares. Over the last 12 months, there were 99 BUYs and 167 SELLs from insiders. Insiders purchased 1,261,418 shares during that period but sold 1,001,785.
In the most recent transaction, MUSSALLEM MICHAEL A sold 19,875 shares of EW for 84.17 per share on Sep 22. After the transaction, the Chairman & CEO now owns 157,353 company shares. In a previous transaction on Sep 08, BOBO DONALD E JR sold 6,725 shares at 90.94 per share. EW shares that CVP,Strategy/Corp Development owns now total 62,561.
Among the insiders who sold shares, Wood Larry L disposed of 7,242 shares on Sep 06 at a per-share price of $89.00. This resulted in the CVP, TAVR holding 202,232 shares of EW after the transaction. In another insider transaction, MUSSALLEM MICHAEL A sold 19,875 shares at $104.74 per share on Aug 15. Company shares held by the Chairman & CEO now total 157,353.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $116.32 with high estimates of $130.00 and low estimates of $97.00. In terms of 52-week highs and lows, EW has a high of $131.73 and a low of $82.92.
As of this writing, EW has an earnings estimate of $0.62 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $0.64 per share and a lower estimate of $0.61.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Sell with a score of 4.53. A total of 15 analysts rated the stock as Buy while 2 rated it as Overweight while 6 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.